Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-15

Clinical Trial Update: Docetaxel, Radiation Therapy, and Prednisone in Treating Patients Who Have Undergone Surgery For Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating docetaxel with radiation therapy and prednisone in patients who had undergone surgery for prostate cancer was terminated; results were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PREDNISONE (Prednisone)
  • Taxotere (docetaxel)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2017-05-15